Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD)

Respiratory Medicine

Volumn 99, Issue 10, 2005, Pages 1241-1248

  Grönke, Lars ^a   Schlenker, Jens ^a   Holz, Olaf ^b   Out, Theo A ^c   Magnussen, Helgo ^a,b   Jörres, Rudolf A ^b,d  

^a Pulmonary Research Institute   (Germany)

^b KRANKENHAUS GROSSHANSDORF   (Germany)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

2 macroglobulin; Forced inspiration; H1 histamine receptor antagonist; Mast cells; Plasma extravasation

Indexed keywords

ALPHA 2 MACROGLOBULIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CETIRIZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; HISTAMINE H1 RECEPTOR AGONIST; HYPERTONIC SOLUTION; PLACEBO; SALBUTAMOL; SODIUM CHLORIDE; THEOPHYLLINE;

ADULT; AEROSOL; AGED; AIRWAY OBSTRUCTION; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; SPUTUM ANALYSIS; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; AGED; BRONCHI; BRONCHODILATOR AGENTS; CETIRIZINE; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SALINE SOLUTION, HYPERTONIC;

EID: 24344482103     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.02.028     Document Type: Article

References (27)

1. R.E. Schoeffel S.D. Anderson R.E. Altounyan Bronchial hyperreactivity in response to inhalation of ultrasonic nebulised solutions of distilled water and saline Br Med J 283 1981 1285-1287
2. K. Richter O. Holz R.A. Jörres M. Mücke H. Magnussen Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease Eur Respir J 14 1999 697-701
3. C. Taube O. Holz M. Mücke R.A. Jörres H. Magnussen Airway response to inhaled hypertonic saline in patients with moderate to severe COPD Am J Respir Crit Care Med 164 2001 1810-1815
4. I.E. Zühlke F. Kanniess K. Richter D. Nielsen-Gode S. Böhme R.A. Jörres H. Magnussen Montelukast attenuates the airway response to hypertonic saline in moderate to severe COPD Eur Respir J 22 2003 926-930
5. F. Kanniess S. Böhme R.A. Jörres H. Magnussen Effect of fluticasone on the airway response to hypertonic saline in patients with COPD Am J Respir Crit Care Med 2004 (Abstract)
6. J.P. Finnerty C. Wilmont S.T. Holgate Inhibition of hypertonic saline-induced bronchoconstriction by terfenadine and flurbiprofen: evidence for the predominant role of histamine Am Rev Respir Dis 140 1989 593-597
7. L.T. Rodwell S.D. Anderson J. Du Toit J.P. Seale Nedocromil sodium inhibits the airway response to hyperosmolar challenge in patients with asthma Am Rev Respir Dis 146 1992 1149-1155
8. J.I. Du Toit S.D. Anderson C.R. Jenkins A.J. Woolcock L.T. Rodwell Airway responsiveness in asthma: Bronchial challenge with histamine and 4.5% sodium chloride before and after budesonide Allergy Asthma Proc 18 1997 7-14
9. L.T. Rodwell S.D. Anderson J.P. Seale Inhaled clemastine inhibits airway narrowing caused by aerosols of non-isotonic saline Eur Respir J 4 1991 1126-1134
10. R.A. Pauwels A.S. Buist P.M. Calverley C.R. Jenkins S.S. Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global initiative for chronic obstructive lung disease (GOLD) workshop summary Am J Respir Crit Care Med 163 2001 1256-1276
11. P.H. Quanjer G.J. Tammeling J.E. Cotes O.F. Pedersen R. Peslin J.C. Yernault Lung volumes and forced ventilatory flows Eur Respir J 16 Suppl. 1993 5-40
12. O. Holz R.A. Jörres S. Koschyk P. Speckin L. Welker H. Magnussen Changes in sputum composition during sputum induction in healthy and asthmatic subjects Clin Exp Allergy 28 1998 284-292
13. N. Frossard O. Benabdesselam A. Purohit N. Mounedji G. Pauli Activity of ebastine (10 and 20 mg) and cetirizine at 24 h of a steady state treatment in the skin of healthy volunteers Fundam Clin Pharmacol 14 2000 409-413
14. American Thoracic Society Standardization of spirometry, 1994 update Am J Respir Crit Care Med 152 1995 1107-1136
15. C. Taube B. Lehnigk K. Paasch D.K. Kirsten R.A. Jörres H. Magnussen Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 2000 216-220
16. R.E. Nocker T.A. Out F.R. Weller M.J. de Riemer H.M. Jansen J.S. van der Zee Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma J Lab Clin Med 136 2000 39-49
17. M. Högman J. Almirall A.C. Mork G.M. Roomans E. Hagelqvist L. Lagerstrand G. Hedenstierna Nebulisation of hypertonic saline causes oedema of the airway wall J Submicrosc Cytol Pathol 29 1997 59-64
18. C. Taube F. Kanniess L. Grönke K. Richter M. Mücke K. Paasch G. Eichler R.A. Jörres H. Magnussen Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma Respir Med 97 2003 568-577
19. M. Einhaus C. Taube L. Welker D. Branscheid K.D. Diemel M. Nakashima R.A. Jörres H. Magnussen Bronchial responsiveness in vitro is reduced in patients with chronic obstructive bronchitis (COPD) as compared to smokers without airway obstruction Am J Respir Crit Care Med 163 2001 A78
20. K. Wedde-Beer C. Hu M.M. Rodriguez G. Piedimonte Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus Am J Physiol Lung Cell Mol Physiol 282 2002 L1143-L1150
21. G. Silber D. Proud J. Warner R. Naclerio A. Kagey-Sobotka L. Lichtenstein P. Eggleston In vivo release of inflammatory mediators by hyperosmolar solutions Am Rev Respir Dis 137 1988 606-612
22. P.A. Eggleston A. Kagey-Sobotka D. Proud N.F. Adkinson Jr L.M. Lichtenstein Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells Am Rev Respir Dis 141 1990 960-964
23. M. Tomaki M. Ichinose M. Miura Y. Hirayama H. Yamauchi N. Nakajima K. Shirato Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis Am J Respir Crit Care Med 151 1995 613-617
24. T.W. Evans D.F. Rogers B. Aursudkij K.F. Chung P.J. Barnes Inflammatory mediators involved in antigen-induced airway microvascular leakage in guinea pigs Am Rev Respir Dis 138 1988 395-399
25. P.R. Germonpré G.F. Joos E. Everaert J.C. Kips R.A. Pauwels Characterization of neurogenic inflammation in the airways of two highly inbred rat strains Am J Respir Crit Care Med 152 1995 1796-1804
26. F.F. Davidson Jr G.W. Burke III Physiologic differentiation of upper and lower airway obstruction Ann Otol Rhinol Laryngol 86 1977 630-632
27. D.F. Schoonbrood T.A. Out A.A. Hart F.J. Habets C.M. Roos H.M. Jansen Nedocromil sodium in obstructive airways disease: Effect on symptoms and plasma protein leakage in sputum Eur Respir J 10 1997 1500-1506